[{"Assets_0_Q2_USD":"42359200000.0","CIK":"59478","CommonStockDividendsPerShareCashPaid_1_Q2_USD":"0.5625","CommonStockDividendsPerShareCashPaid_2_Q2_USD":"1.125","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.25","EarningsPerShareBasic_2_Q2_USD":"0.92","EarningsPerShareDiluted_1_Q2_USD":"-0.25","EarningsPerShareDiluted_2_Q2_USD":"0.92","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q2_USD":"65600000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"1954000000.0","NetIncomeLoss_1_Q2_USD":"-259900000.0","NetIncomeLoss_2_Q2_USD":"957500000.0","OfficialName":"Eli Lilly and Company Common Stock","RevenuesConverted_1_Q2_USD":"6355200000.0","RevenuesConverted_2_Q2_USD":"12055200000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"11620800000.0","StockholdersEquity_0_Q2_USD":"11555200000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"1030200000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"1041600000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"1030200000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"1039600000.0","filed":"20180725","footnote":null,"form":"10-Q","fp":"Q2","fy":"2018.0","name":"LILLY ELI & CO","period":"20180630","qtrs":"0","uom":"USD"}]